← All organizations
Highest phase reached
Phase 2
First clinical trial
Dec 31, 2021Last known activity
Jul 1, 2024
Timeline
2010s
- Jun 1, 2018
Myeloid Therapeutics— Founded
Drugs by trial phase (5 distinct, 3 trials)
Phase 2 (3 own, 0 via acquisition)
Recent trials (6)
- NCT06478693OfficialPhase 1Jul 1, 2024
- NCT06478693Lead sponsorPhase 1Jul 1, 2024
- NCT05969041Lead sponsorPhase 1Aug 2, 2023
- NCT05969041Study directorPhase 1Aug 2, 2023
- NCT05138458Study directorPhase 1/Phase 2Dec 31, 2021
- NCT05138458Lead sponsorPhase 1/Phase 2Dec 31, 2021
Details
- Founded
- Cambridge, MA, US Jun 1, 2018
- Last known activity
- Jul 1, 2024